Excessive exposure to anionic surfaces maintains autoantibody response to β2-glycoprotein I in patients with antiphospholipid syndrome

被引:41
作者
Yamaguchi, Yukie [1 ,2 ]
Seta, Noriyuki [1 ]
Kaburaki, Junichi [3 ]
Kobayashi, Kazuko [4 ]
Matsuura, Eiji [4 ]
Kuwana, Masataka [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku,Div Rheumatol, Tokyo 1608582, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa 232, Japan
[3] Tokyo Elect Power Co Hosp, Dept Internal Med, Tokyo, Japan
[4] Okayama Univ, Grad Sch Med Dentistry & Pharmaceut Sci, Dept Cell Chem, Okayama, Japan
关键词
D O I
10.1182/blood-2007-07-100008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti phospholipid syndrome (APS) is an autoimmune prothrombotic disorder associated with autoantibodies to phospholipid (PL)-binding proteins, such as beta(2)-glycoprotein I (beta(2)GPI). We have recently reported that binding of beta(2)GPI to anionic PL facilitates processing and presentation of the cryptic B(2)GPI epitope that activates pathogenic autoreactive T cells. To clarify mechanisms that induce sustained presentation of the dominant antigenic beta(2)GPI determinant in patients with APS, T-cell proliferation induced by beta(2)GPI-treated phosphatidylserine liposome (beta(2)GPI/PS) was evaluated in bulk peripheral blood mononuclear cell cultures. T cells from patients with APS responded to beta(2)GPI/PS in the presence of immunoglobulin G (IgG) anti-beta(2)GPI antibodies derived from APS plasma, and this response was completely inhibited either by the depletion of monocytes or by the addition of anti-Fc gamma RI antibody. These findings indicate that efficient presentation of the cryptic determinants can be Fc gamma RI-mediated uptake of beta(2)GPI-bound anionic surfaces in the presence of IgG anti-beta(2)GPI antibodies. Finally, beta(2)GPI-bound oxidized LDL or activated platelets also induced the specific T-cell response. Continuous exposure to these anionic surfaces may play a critical role in maintaining the pathogenic anti-beta(2)GPI antibody response in patients with APS.
引用
收藏
页码:4312 / 4318
页数:7
相关论文
共 40 条
[1]   Budding, vesiculation and permeabilization of phospholipid membranes -: evidence for a feasible physiologic role of β2-glycoprotein I and pathogenic actions of anti-β2-glycoprotein I antibodies [J].
Ambrozic, A ;
Bozic, B ;
Kveder, T ;
Majhenc, J ;
Arrigler, V ;
Svetina, S ;
Rozman, B .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1740 (01) :38-44
[2]  
Amengual O, 1998, ARTHRITIS RHEUM, V41, P1513, DOI 10.1002/1529-0131(199808)41:8<1513::AID-ART28>3.0.CO
[3]  
2-7
[4]   Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome:: preferential recognition of the major phospholipid-binding site [J].
Arai, T ;
Yoshida, K ;
Kaburaki, J ;
Inoko, H ;
Ikeda, Y ;
Kawakami, Y ;
Kuwana, M .
BLOOD, 2001, 98 (06) :1889-1896
[5]   IMMUNIZATION WITH ANTICARDIOLIPIN COFACTOR (BETA-2-GLYCOPROTEIN-I) INDUCES EXPERIMENTAL ANTIPHOSPHOLIPID SYNDROME IN NAIVE MICE [J].
BLANK, M ;
FADEN, D ;
TINCANI, A ;
KOPOLOVIC, J ;
GOLDBERG, I ;
GILBURD, B ;
ALLEGRI, F ;
BALESTRIERI, G ;
VALESINI, G ;
SHOENFELD, Y .
JOURNAL OF AUTOIMMUNITY, 1994, 7 (04) :441-455
[6]  
BOGDAN W, 2000, THROMB RES, V99, P495
[7]   Avidity of anti-beta-2-glycoprotein I antibodies [J].
Bozic, B ;
Cucnik, S ;
Kveder, T ;
Rozman, B .
AUTOIMMUNITY REVIEWS, 2005, 4 (05) :303-308
[8]   R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation [J].
Braselmann, Sylvia ;
Taylor, Vanessa ;
Zhao, Haoran ;
Wang, Su ;
Sylvain, Catherine ;
Baluom, Muhammad ;
Qu, Kunbin ;
Herlaar, Ellen ;
Lau, Angela ;
Young, Chi ;
Wong, Brian R. ;
Lovell, Scott ;
Sun, Thomas ;
Park, Gary ;
Argade, Ankush ;
Jurcevic, Stipo ;
Pine, Polly ;
Singh, Rajinder ;
Grossbard, Elliott B. ;
Payan, Donald G. ;
Masuda, Esteban S. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) :998-1008
[9]   The antiphospholipid/cofactor syndromes: A primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays [J].
Cabral, AR ;
Amigo, MC ;
Cabiedes, J ;
AlarconSegovia, D .
AMERICAN JOURNAL OF MEDICINE, 1996, 101 (05) :472-481
[10]   Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome [J].
Cervera, R ;
Font, J ;
Gómez-Puerta, JA ;
Espinosa, G ;
Cucho, M ;
Bucciarelli, S ;
Ramos-Casals, M ;
Ingelmo, M ;
Piette, JC ;
Shoenfeld, Y ;
Asherson, RA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1205-1209